Exploiting tumor-associated dendritic cell heterogeneity for novel cancer therapies.

Keirsse, Jiri; Van Damme, Helena; Van Ginderachter, Jo A; Laoui, Damya

Keirsse, Jiri; Van Damme, Helena; Van Ginderachter, Jo A; Laoui, Damya.

Afiliação

Keirsse J; Myeloid Cell Immunology Lab, VIB-UGent Center for Inflammation Research, Ghent, Belgium; and.
Van Damme H; Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium.
Van Ginderachter JA; Myeloid Cell Immunology Lab, VIB-UGent Center for Inflammation Research, Ghent, Belgium; and.
Laoui D; Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium.

J Leukoc Biol ; 102(2): 317-324, 2017 08.

Article em En | MEDLINE | ID: mdl-28389620

Assuntos

Células Dendríticas/imunologia; Neoplasias/imunologia; Animais; Humanos

Palavras-chave

DC vaccination; TADC; immunogenic DC; tolerogenic DC

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Neoplasias Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: J Leukoc Biol Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google